[1] Angeli P, Ginès P, Wong F, et al.Diagnosis and management of acute kidney injury in patients with cirrhosis:revised consensus recommendations of the International Club of Aseites.Journal of Hepatology,2015,62:968-974. [2] Shusterman B, Mchedishvili G, Rosner MH. Outcomes for hepatorenal syndrome and acute kidney injury in patients undergoing liver transplantation: a single-center experience. Transplant Proc, 2007,39:1496-500. [3] Belcher JM, Parikh CR, Garcia-Tsao G. Acute kidney injury in patients with cirrhosis: perils and promise. Clin Gastroenterol Hepatol, 2013,11:1550-1558. [4] Kjeldsen L, Johnsen AH, Sengeløv H, et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem, 1993,14:10425-10432. [5] 皮海. 血清NGAL检测对AKI早期辅助诊断的研究. 中国实验诊断学,2016,20:1749-1750. [6] 徐钢.急性肾小管坏死的诊治进展.临床肾脏病杂志,2010,10:444-446. [7] Gan J, Zhou X. Comparison of urine neutrophil gelatinase-associated lipocalin and interleukin-18 in prediction of acute kidney injury in adults. Medicine (Baltimore), 2018,97:e12570. [8] Huelin P, Piano S, Solà E, et al. Validation of a staging system for acute kidney injury in patients with cirrhosis and association with acute-on-chronic liver failure. Clin Gastroenterol Hepatol, 2017,15:438-445. [9] Kim H, Hur M, Cruz DN, et al. Plasma neutrophil gelatinase-associated lipocalin as a biomarker for acute kidney injury in critically ill patients with suspected sepsis. Clin Biochem, 2013,46:1414-1418. [10] Hekmat R, Mohebi M. Comparison of serum creatinine, cystatin C, and neutrophil gelatinase-associated lipocalin for acute kidney injury occurrence according to risk, injury, failure, loss, and end-stage criteria classification system in early after living kidney donation. Saudi J Kidney Dis Transpl, 2016, 27:659-664. [11] Yeung ACY, Morozov A, Robertson FP, et al. Neutrophil gelatinase-associated lipocalin (NGAL) in predicting acute kidney injury following orthotopic liver transplantation: a systematic review. Int J Surg, 2018,59:48-54. [12] Virzì GM, Breglia A, Brocca A, et al. Levels of proinflammatory cytokines, oxidative stress, and tissue damage markers in patients with acute heart failure with and without cardiorenal syndrome type 1. Cardiorenal Med, 2018,8:321-331. [13] Gombert A, Martin L, Foldenauer AC, et al. Comparison of urine and serum neutrophil gelatinase-associated lipocalin after open and endovascular thoraco-abdominal aortic surgery and their meaning as indicators of acute kidney injury. Vasa, 2019,48:79-87. [14] Lee CC, Chang CH, Chen SW, et al. Preoperative risk assessment improves biomarker detection for predicting acute kidney injury after cardiac surgery. PLoS One, 2018, 13:e0203447. [15] Verna EC, Brown RS, Farrand E, et al. Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis. Dig Dis Sci, 2012,57:2362-2370. [16] Fagundes C, Pepin MN, Guevara M, et al. Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis. J Hepatol, 2012,57:267-273. [17] Belcher JM,Sanyal AJ,Peixoto AJ,et al. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury.Hepatology, 2014,60:622-632. [18] Ariza X, Solà E, Elia C, et al. Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis. PLoS One. 2015, 4,10:e0128145. [19] Jaques DA, Spahr L, Berra G, et al. Biomarkers for acute kidney injury in decompensated cirrhosis: a prospective study. Nephrology (Carlton), 2019,24:170-180. |